The short answer: before you pay cash, ask your plan exactly what changed and whether an exception or appeal applies. If the coverage is truly gone, the lowest posted cash prices for FDA-approved GLP-1s start at $149 a month for pills and $299 for a starting dose of Zepbound, or $199 for two introductory Wegovy fills before it becomes $349. Higher doses run $299 to $449 a month. Compounded versions are listed for less, but they are not FDA-approved.
Why this is happening
Dylan Scott at Vox laid out the problem on October 15: "But now, private plans are pulling back from GLP-1 coverage." He cites a Business Group on Health survey finding at least 10% of employer plans that cover GLP-1s for weight loss say they are likely to stop in 2027, and a Mercer survey in which 6% of large employers dropped coverage in 2026. This post is about what to do next.
Step 1: Find out what actually changed
Each kind of change has a different fix.
- The drug left the formulary, but the plan still covers weight-loss drugs. Your prescriber can file an exception request. For plans that must cover essential health benefits (generally individual and small-group plans), federal rules require a decision within 72 hours, or 24 hours when your health is at serious risk, and an independent review if the plan says no. Large employer plans set their own exception process, so ask for it in writing.
- A claim or prior authorization was denied. You can file an internal appeal within 180 days of the denial, according to HealthCare.gov. After a final denial, you have 4 months to request an external review, which covers, in HealthCare.gov's words, "Any denial that involves medical judgment where you or your provider may disagree with the health insurance plan."
- Your employer removed the benefit for everyone. That is a plan design choice rather than a judgment about you, so an appeal may not reverse it. Still, ask HR whether the exclusion covers every use of the drug or only weight management.
- On Medicare? Vox notes Medicare launched a $50-a-month program this summer. Ask your Part D plan whether you qualify.
Step 2: Compare the cash routes
Prices below come from each program's own page, checked October 17, 2026. All are self-pay and need a prescription.
| Medication (FDA-approved) | Where | Starting dose | Higher doses | What "a month" means |
|---|---|---|---|---|
| Zepbound vials or KwikPen | LillyDirect | $299 (2.5 mg) | $399 (5 mg); $449 (7.5 to 15 mg) if you refill within 45 days, otherwise $499 to $699 | 28 days. Needles and syringes extra |
| Wegovy pen | NovoCare, or a TrumpRx coupon at your pharmacy | $199 for the first two fills of 0.25 or 0.5 mg (new patients, through Dec. 31, 2026) | $349 (0.25 to 2.4 mg); $399 (7.2 mg) | 1 box of 4 pens |
| Wegovy pill | NovoCare | $149 (1.5 mg) | $199 (4 mg); $299 (9 and 25 mg) | 30 tablets |
| Foundayo pill | LillyDirect | $149 (0.8 mg) | $149 (2.5 mg) and $199 (5.5 mg) through Dec. 31, 2026; $299 (9 to 17.2 mg; top two doses need a refill within 45 days) | 30 days |
A few notes from the fine print:
- TrumpRx matches the manufacturers. Its Zepbound page sends you to LillyDirect, and its Wegovy price is the same NovoCare offer as a pharmacy coupon.
- Subscriptions can cost less if you commit. Novo Nordisk's March 31, 2026 release lists Wegovy pen subscriptions through select telehealth providers at $329, $299, or $249 a month for 3, 6, or 12 months.
- Costco carries the Wegovy pill, per a Novo Nordisk release. We found no Costco-specific GLP-1 price on Costco's site, so ask the pharmacy whether it honors the manufacturer offer.
- Mark Cuban Cost Plus Drugs does not list semaglutide or tirzepatide in its public pricing data. It does list generic liraglutide for weight management, an older once-daily injection, at $701.50 for a box of five pens, plus a $15 dispensing fee and $55 cold-chain shipping. Whether it fits you is a question for your prescriber.
What a year costs
Because Lilly and NovoCare price by 28-day or four-pen "months," a year is 13 fills, not 12. At the posted maintenance prices:
- Zepbound, 7.5 mg or higher, refilled on time: 13 × $449 = $5,837
- Wegovy pen, 0.25 to 2.4 mg: 13 × $349 = $4,537
- Wegovy pill at 9 or 25 mg, or Foundayo at 9 mg or higher: $299 per 30 days, about $3,640
These are different medications at different doses: prices, not a ranking. Which one fits you is your prescriber's call.
What about compounded GLP-1s?
Compounded semaglutide and tirzepatide are made by state-licensed pharmacies for an individual prescription. The FDA is direct about the trade-off: "compounded drugs are not FDA approved. This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed." The agency says they "should only be used in patients whose medical needs cannot be met by an FDA-approved drug," and that patients should fill the prescription "at a state-licensed pharmacy." The shortage-era flexibility for copies of these drugs ended in 2025, on March 5 for tirzepatide and April 24 for semaglutide, according to an FDA warning letter.
For prices, the NexLife October 2026 GLP-1 Price Index checked 21 online programs on October 7 and 8, 2026. NexLife sells compounded GLP-1s itself, and these are all-in program prices.
- Compounded tirzepatide: $129 to $399 a month at 14 programs, median $222. The $129 price covers low doses only.
- Compounded semaglutide: $79 to $299 a month at 16 programs, median $175. The $79 price is a labeled sale price.
- Dose matters: 10 of 14 tirzepatide programs and 10 of 16 semaglutide programs say their price stays the same as the dose rises. Ask before you start.
Step 3: Talk to your prescriber before you switch or stop
Questions you can ask include:
- If my plan won't cover this, which covered medications could work for me instead?
- If I switch, how do we handle the dose, so I don't restart from the beginning or jump too far ahead?
- If I need to stop, should I step down, and what should I watch for afterward?
These switches are easier to plan than to undo.
Where Temi fits
At Temi, a licensed physician reviews every request, and you choose the pharmacy that fills it, including after comparing the routes above. We charge for the clinical review, not for prescribing, so a decision not to prescribe is part of the service. A new prescription review is $79, or $0 with Temi Care ($449 a year). For compounded GLP-1 through a partner pharmacy, the prescription service is $39 for non-members, and the medication is marked up no more than 15%. Temi also handles everyday refills of other medications, at $15 per renewal or $0 with Temi Care. We serve patients in Arizona, California, Colorado, Delaware, Florida, Michigan, Missouri, New York, North Carolina, Ohio, Pennsylvania, Texas, and Wisconsin.
Prices were checked on October 17, 2026, on each program's own page except where a press release is linked. They change often, so check before you buy.
